Not applicableStudy completedNCT06369662What this trial is testingCD155 Expression in Acute Myeloid LeukemiaWho this might be right forNeoplasmsHematologic NeoplasmsLeukemia+2 more Assiut University 93
Testing effectiveness (Phase 2)Ended earlyNCT01745913What this trial is testingRandomized HaploCord Blood Transplantation vs. Double Umbilical Cord Blood Transplantation for Hematologic MalignanciesWho this might be right forAcute Myelogenous LeukemiaMyelodysplastic SyndromeAcute Lymphocytic Leukemia+2 more Weill Medical College of Cornell University 2
Very early researchStudy completedNCT05907603What this trial is testingResearch Development（RD）13-02 Chimeric Antigen Receptor(CAR) -T Cell Injection for Patients With r/r Cluster Of Differentiation 7（CD7）+ T-Acute Lymphoblastic Leukemia(ALL)/T-Lymphoblastic Lymphoma(LBL) /Acute Myelogenous Leukemia(AML)Who this might be right forNeoplasmsHematologic NeoplasmsHematologic Diseases Kai Lin Xu，MD 8
Testing effectiveness (Phase 2)Ended earlyNCT00957580What this trial is testingTrial of Pimasertib in Hematological MalignanciesWho this might be right forLeukemia, Myeloid, AcuteHematologic Neoplasms EMD Serono 81
Testing effectiveness (Phase 2)Active Not RecruitingNCT06001385What this trial is testingHLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD ProphylaxisWho this might be right forAcute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAcute Leukemia+8 more Center for International Blood and Marrow Transplant Research 313
Testing effectiveness (Phase 2)Ended earlyNCT00593554What this trial is testingPhase 2 Haplotype Mismatched HSCT in Patients With Hematological MalignanciesWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplasia+1 more Sherif S. Farag 9
Testing effectiveness (Phase 2)Study completedNCT00448201What this trial is testingReduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other DiseaseWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+2 more UNC Lineberger Comprehensive Cancer Center 71
Not applicableEnded earlyNCT00813501What this trial is testingImmunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other DiseasesWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseInfection+7 more City of Hope Medical Center 60
Early research (Phase 1)Looking for participantsNCT03802695What this trial is testingOrca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic MalignanciesWho this might be right forAcute Myeloid LeukemiaMyelodysplastic SyndromesMixed Phenotype Acute Leukemia+1 more Orca Biosystems, Inc. 300
Testing effectiveness (Phase 2)Study completedNCT00467961What this trial is testingStem Cell Transplantation for Patients With Cancers of the BloodWho this might be right forCML (Chronic Myelogenous Leukemia)CLL (Chronic Lymphocytic Leukemia)AML (Acute Myelogenous Leukemia)+2 more National Heart, Lung, and Blood Institute (NHLBI) 61
Testing effectiveness (Phase 2)Study completedNCT00309842What this trial is testingMyeloablative Umbilical Cord Blood Transplantation in Hematological DiseasesWho this might be right forAcute Myeloid LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+10 more Masonic Cancer Center, University of Minnesota 213
Early research (Phase 1)Study completedNCT01321346What this trial is testingPanobinostat In Children With Refractory Hematologic MalignanciesWho this might be right forLymphoblastic Leukemia, Acute, ChildhoodMyelogenous Leukemia, Acute, ChildhoodHodgkin's Disease+1 more Therapeutic Advances in Childhood Leukemia Consortium 30
Early research (Phase 1)Study completedNCT02270788What this trial is testingCrenolanib in Combination With Sorafenib in Patients With Refractory or Relapsed Hematologic MalignanciesWho this might be right forAcute Myeloid Leukemia St. Jude Children's Research Hospital 10
Early research (Phase 1)Study completedNCT00003962What this trial is testingInterleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Early research (Phase 1)Looking for participantsNCT05088356What this trial is testingReduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted GraftWho this might be right forAllogeneic Hematopoietic Cell Transplantation (HCT)Advanced Hematologic MalignanciesAcute Leukemia+3 more Stanford University 77
Early research (Phase 1)Study completedNCT00458250What this trial is testingFeasibility of Haploidentical Hematopoietic Stem Cell Transplantation Using CAMPATH-1HWho this might be right forLeukemia, Myeloid, AcuteLeukemia, Lymphoblastic, Acute Tehran University of Medical Sciences 10
Not applicableStudy completedNCT00988013What this trial is testingIntensity Modulated Total Marrow Irradiation (IM-TMI) for Advanced Hematologic MalignanciesWho this might be right forAcute Myeloid LeukemiaLymphoblastic LeukemiaAcute Leukemia+2 more University of Illinois at Chicago 14
Testing effectiveness (Phase 2)Study completedNCT00381550What this trial is testing3-AP and Fludarabine in Treating Patients With Myeloproliferative Disorders, Chronic Myelomonocytic Leukemia, or Accelerated Phase or Blastic Phase Chronic Myelogenous LeukemiaWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAtypical Chronic Myeloid Leukemia, BCR-ABL1 NegativeBlastic Phase Chronic Myelogenous Leukemia+7 more National Cancer Institute (NCI) 35
Early research (Phase 1)Looking for participantsNCT07321626What this trial is testingRomiplostim N01 for Platelet Recovery After Haploidentical HSCTWho this might be right forAcute Myeloid LeukemiaMDS (Myelodysplastic Syndrome)Delayed Platelet Engraftment+1 more First Affiliated Hospital of Zhejiang University 130
Early research (Phase 1)Ended earlyNCT02683395What this trial is testingPLX51107 in Advanced MalignanciesWho this might be right forSolid TumorsAcute Myeloid LeukemiaMyelodysplastic Syndrome+1 more Plexxikon 50